The X-Linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Kido, Tatsuo ^a   Ou, Jing Hsiung James ^b   Lau, Yun Fai Chris ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; HEPATITIS B VIRUS X PROTEIN; PROTEASOME; PROTEIN SUBUNIT; UBIQUITIN C; MESSENGER RNA; NUCLEAR PROTEIN; SE20 4 PROTEIN, HUMAN; SE20-4 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UBIQUITIN;

ARTICLE; CARCINOGENESIS; EPIGENETICS; GENE MUTATION; HEPATITIS B VIRUS; HUMAN; IMMUNOPRECIPITATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VIRUS GENOME; VIRUS REPLICATION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; KIDNEY; LIVER TUMOR; METABOLISM; PROTEIN PROCESSING; WESTERN BLOTTING;

HEPATITIS B VIRUS;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; HUMANS; KIDNEY; LIVER NEOPLASMS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; UBIQUITIN;

EID: 79960913881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022979     Document Type: Article

References (41)

1. Park YJ, Luger K, (2006) Structure and function of nucleosome assembly proteins. Biochem Cell Biol 84: 549-558.
2. Muto S, Senda M, Akai Y, Sato L, Suzuki T, et al. (2007) Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc Natl Acad Sci U S A 104: 4285-4290.
3. Ozbun LL, Martinez A, Jakowlew SB, (2005) Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear and cytoplasmic localization and increases TGF-beta1-responsive transcription in primates. Biochim Biophys Acta 1728: 163-180.
4. Scully RE, (1970) Gonadoblastoma. A review of 74 cases. Cancer 25: 1340-1356.
5. Page DC, (1987) Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101 (Suppl): 151-155.
6. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, et al. (1995) Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 14: 210-214.
7. Lau YF, Lau HW, Komuves LG, (2003) Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 101: 250-260.
8. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, et al. (2005) TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 93: 458-463.
9. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, et al. (2005) Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 26: 1856-1867.
10. Oram SW, Liu XX, Lee TL, Chan WY, Lau YF, (2006) TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6: 154.
11. Li Y, Lau YF, (2008) TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 27: 6141-6150.
12. Kido T, Lau YF, (2008) The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int J Cancer 123: 1573-1585.
13. Tu Y, Wu W, Wu T, Cao Z, Wilkins R, et al. (2007) Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 282: 11722-11731.
14. Kandalaft LE, Zudaire E, Portal-Nunez S, Cuttitta F, Jakowlew SB, (2008) Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis 29: 1282-1289.
15. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
16. Beasley RP, (1988) Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61: 1942-1956.
17. Lavanchy D, (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 (Suppl 1): S1-3.
18. Neuveut C, Wei Y, Buendia MA, (2010) Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52: 594-604.
19. Cheng AS, Wong N, Tse AM, Chan KY, Chan KK, et al. (2007) RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. Cancer Lett 253: 43-52.
20. Keasler VV, Hodgson AJ, Madden CR, Slagle BL, (2007) Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81: 2656-2662.
21. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, et al. (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19: 810-819.
22. Kim CM, Koike K, Saito I, Miyamura T, Jay G, (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320.
23. Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, et al. (2010) Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2: 32ra35.
24. Hwang GY, Lin CY, Huang LM, Wang YH, Wang JC, et al. (2003) Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol 41: 5598-5603.
25. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, et al. (1999) Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 73: 7231-7240.
26. Xian L, Zhao J, Wang J, Fang Z, Peng B, et al. (2009) p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2. Mol Biol Rep.
27. Park SG, Min JY, Chung C, Hsieh A, Jung G, (2009) Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx. Cancer Lett 282: 229-237.
28. Li J, Xu Z, Zheng Y, Johnson DL, Ou JH, (2002) Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol 76: 5875-5881.
29. Kim JH, Sohn SY, Benedict Yen TS, Ahn BY, (2008) Ubiquitin-dependent and-independent proteasomal degradation of hepatitis B virus X protein. Biochem Biophys Res Commun 366: 1036-1042.
30. Fang S, Weissman AM, (2004) A field guide to ubiquitylation. Cell Mol Life Sci 61: 1546-1561.
31. Yang Y, Kitagaki J, Dai RM, Tsai YC, Lorick KL, et al. (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res 67: 9472-9481.
32. Pick E, Hofmann K, Glickman MH, (2009) PCI complexes: Beyond the proteasome, CSN, and eIF3 Troika. Mol Cell 35: 260-264.
33. Funakoshi M, Li X, Velichutina I, Hochstrasser M, Kobayashi H, (2004) Sem1, the yeast ortholog of a human BRCA2-binding protein, is a component of the proteasome regulatory particle that enhances proteasome stability. J Cell Sci 117: 6447-6454.
34. Pickart CM, Cohen RE, (2004) Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 5: 177-187.
35. Welchman RL, Gordon C, Mayer RJ, (2005) Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6: 599-609.
36. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, et al. (2008) Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. J Mol Biol 383: 693-712.
37. Chai Z, Sarcevic B, Mawson A, Toh BH, (2001) SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem 276: 33665-33674.
38. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, et al. (1999) Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86: 1143-1150.
39. Yin J, Zhang H, Li C, Gao C, He Y, et al. (2008) Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 29: 1685-1691.
40. Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, et al. (2007) Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A 104: 2571-2578.
41. Liu Y, Wang L, Zheng P, (2010) X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity. Trends Genet 26: 260-265.